Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Under-recognition of 22q11.2 deletion in adult Chinese patients with conotruncal anomalies: implications in transitional care.
[22q11.2 deletion syndrome]
22
q
11
.
2
deletion
syndrome
(
22
q
11
.
2
DS
)
is
a
multi-systemic
disorder
with
high
phenotypic
variability
.
Under-diagnosis
in
adults
is
common
and
recognition
of
facial
dysmorphic
features
can
be
affected
by
age
and
ethnicity
.
This
study
aims
to
determine
the
prevalence
of
undiagnosed
22
q
11
.
2
DS
in
adult
Chinese
patients
with
conotruncal
anomalies
and
to
delineate
their
facial
dysmorphisms
and
extra
-
cardiac
manifestations
.
We
recruited
consecutively
156
patients
with
conotruncal
anomalies
in
an
adult
congenital
heart
disease
(
CHD
)
clinic
in
Hong
Kong
and
screened
for
22
q
11
.
2
DS
using
fluorescence-
PCR
and
fluorescence
in
-situ
hybridization
.
Assessment
for
dysmorphic
features
was
performed
by
a
cardiologist
at
initial
screening
and
then
by
a
clinical
geneticist
upon
result
disclosure
.
Clinical
photographs
were
taken
and
childhood
photographs
collected
.
Eighteen
patients
(
11
.
5
%
)
were
diagnosed
with
22
q
11
.
2
DS
,
translating
into
1
previously
unrecognized
diagnosis
of
22
q
11
.
2
DS
in
every
10
adult
patients
with
conotruncal
anomalies
.
While
dysmorphic
features
were
detected
by
our
clinical
geneticist
in
all
patients
,
only
two
-thirds
were
considered
dysmorphic
by
our
cardiologist
upon
first
assessment
.
Evolution
of
facial
dysmorphic
features
was
noted
with
age
.
Extra
-
cardiac
manifestations
included
velopharyngeal
incompetence
or
cleft
palate
(
44
%
)
,
hypocalcemia
(
39
%
)
,
neurodevelopmental
anomalies
(
33
%
)
,
thrombocytopenia
(
28
%
)
,
psychiatric
disorders
(
17
%
)
,
epilepsy
(
17
%
)
and
hearing
loss
(
17
%
)
.
We
conclude
that
under-diagnosis
of
22
q
11
.
2
DS
in
Chinese
adults
with
conotruncal
defects
is
common
and
facial
dysmorphic
features
may
not
be
reliably
recognized
in
the
setting
of
adult
CHD
clinic
,
referral
for
genetic
evaluation
and
molecular
testing
for
22
q
11
.
2
DS
should
be
offered
to
patients
with
conotruncal
defects
.
Diseases
Validation
Diseases presenting
"epilepsy"
symptom
22q11.2 deletion syndrome
adrenomyeloneuropathy
alexander disease
canavan disease
classical phenylketonuria
cohen syndrome
cowden syndrome
familial hypocalciuric hypercalcemia
gm1 gangliosidosis
hereditary cerebral hemorrhage with amyloidosis
hirschsprung disease
homocystinuria without methylmalonic aciduria
kabuki syndrome
locked-in syndrome
lymphangioleiomyomatosis
monosomy 21
neonatal adrenoleukodystrophy
pendred syndrome
phenylketonuria
proteus syndrome
pyruvate dehydrogenase deficiency
sneddon syndrome
wolf-hirschhorn syndrome
zellweger syndrome
This symptom has already been validated